EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2025 (TTM): S$0.17

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is S$0.17. In 2024 the company made an earnings per share (EPS) of S$0.18 an increase over its 2023 EPS that were of S$0.12.

EPS history for Jiangsu Hengrui Medicine from 2000 to 2025

Annual EPS

Year	EPS	Change
2025 (TTM)	S$0.17	-2.73%
2024	S$0.18	42.43%
2023	S$0.12	8.77%
2022	S$0.11	-20.62%
2021	S$0.14	-26.59%
2020	S$0.20	27.24%
2019	S$0.15	28.41%
2018	S$0.12	20.04%
2017	S$0.09994	31.21%
2016	S$0.07616	11.46%
2015	S$0.06833	36.27%
2014	S$0.05015	19.77%
2013	S$0.04187	18.05%
2012	S$0.03547	23.9%
2011	S$0.02863	26.9%
2010	S$0.02256	12.37%
2009	S$0.02008	56.6%
2008	S$0.01282	9.18%
2007	S$0.01174	114.48%
2006	S$0.005475	64.83%
2005	S$0.003321	35.55%
2004	S$0.002450	29.73%
2003	S$0.001889	19.86%
2002	S$0.001576	-2.71%
2001	S$0.001620	1.02%
2000	S$0.001603

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions